Russell Enns is Sr. VP & Regulatory at CEPHEID (CPHD). They have made 2 open-market trades across 1 company since 2007, most recently 2012-12-31.
CIK 0001289322
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CPHD | 6,528 | $346K |
Shares reported on the most recent Form 4, priced at the 2013-01-03 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CPHD | SELL | 2012-02-07 | 2012-02-09 | $42.68 | $1.6M | -9.3% | +1.0% | +1.0% |
| CPHD | SELL · 10b5-1 | 2011-07-22 | 2011-07-26 | $39.85 | $1.2M | -9.3% | +1.0% | +1.0% |
| CPHD | SELL · 10b5-1 | 2011-05-31 | 2011-06-02 | $31.72 | $1.4M | -9.3% | +1.0% | +1.0% |
| CPHD | SELL · 10b5-1 | 2011-04-26 | 2011-04-27 | $31.94 | $623K | -9.3% | +1.0% | +1.0% |
| CPHD | SELL · 10b5-1 | 2011-04-04 | 2011-04-07 | $29.10 | $2.8M | -9.3% | +1.0% | +1.0% |
| CPHD | SELL · 10b5-1 | 2011-04-01 | 2011-04-05 | $28.43 | $355K | -9.3% | +1.0% | +1.0% |
| CPHD | SELL · 10b5-1 | 2011-03-04 | 2011-03-08 | $27.35 | $547K | -9.3% | +1.0% | +1.0% |
| CPHD | SELL · 10b5-1 | 2010-10-22 | 2010-10-26 | $20.00 | $225K | -9.3% | +1.0% | +1.0% |
| CPHD | SELL · 10b5-1 | 2008-07-10 | 2008-07-11 | $29.00 | $1.5M | -9.3% | +1.0% | +1.0% |
| CPHD | SELL · 10b5-1 | 2008-07-08 | 2008-07-09 | $29.00 | $505K | -9.3% | +1.0% | +1.0% |
| CPHD | SELL · 10b5-1 | 2008-06-17 | 2008-06-17 | $28.00 | $840K | -9.3% | +1.0% | +1.0% |
| CPHD | SELL · 10b5-1 | 2008-02-29 | 2008-02-29 | $27.77 | $833K | -9.3% | +1.0% | +1.0% |
| CPHD | SELL | 2007-11-29 | 2007-12-03 | $22.00 | $440K | -9.3% | +1.0% | +1.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.